Determination of MK-383, a non-peptide fibrinogen receptor antagonist, in human plasma and urine by radioimmunoassay
- 31 August 1994
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 12 (8), 1047-1053
- https://doi.org/10.1016/0731-7085(94)e0009-p
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man.Circulation, 1993
- Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitorsJournal of Medicinal Chemistry, 1992
- Platelet inhibitor agents in cardiovascular disease: An updateJournal of the American College of Cardiology, 1989
- Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.Circulation, 1988
- Biochemical evidence of platelet activation in patients with persistent unstable anginaJournal of the American College of Cardiology, 1987
- New Perspectives in Cell Adhesion: RGD and IntegrinsScience, 1987
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Correlation between fibrinogen binding to human platelets and platelet aggregabilityBlood, 1980
- Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated plateletsNature, 1980